Therefore, it is crucial to initiate platelet-boosting therapy in a timely manner based on the individual circumstances of patients experiencing CTIT.<h4>Methods</h4>Patients who developed cancer treatment-induced thrombocytopenia and received Rh-TPO treatment from January 2023 and December 2023 were obtained for establishing the dataset. Here, TPO is linked to cancer.